Evidence map›Paper›PMID 12409365›Full record

ArticleJournal of clinical microbiology2002

Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.

Belkys Fernández-Torres, Francisco J Cabañes, Alfonso J Carrillo-Muñoz, Alexandre Esteban, Isabel Inza, Lourdes Abarca, Josep Guarro

Abstract readComparative StudyEvaluation StudyMulticenter Study
In one paragraph

Article in Journal of clinical microbiology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Specific Primers and Nested PCR FindJournal of fungi (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Virulence and Antifungal Susceptibility ofAntibiotics (Basel, Switzerland) · 2021
    Article
  5. Article
  6. Article
  7. LowCurrent medical mycology · 2020
    Article
  8. Therapy and Antifungal Susceptibility Profile ofJournal of fungi (Basel, Switzerland) · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Belkys Fernández-TorresUnitat de Microbiología, Facultat de Medicina, Universitat Rovira i Virgili, Reus, Barcelona, Spain.
Francisco J Cabañes
Alfonso J Carrillo-Muñoz
Alexandre Esteban
Isabel Inza
Lourdes Abarca
Josep Guarro

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A multicenter study was conducted to define the most suitable testing conditions for antifungal susceptibility of dermatophytes. Broth microdilution MICs of clotrimazole, itraconazole, and terbinafine were determined in three centers against 60 strains of dermatophytes. The effects of inoculum density (ca. 10(3) and 10(4) CFU/ml), incubation time (3, 7, and 14 days), endpoint criteria for MIC determination (complete [MIC-0] and prominent [MIC-2] growth inhibition), and incubation temperature (28 and 37 degrees C) on intra- and interlaboratory agreement were analyzed. The optimal testing conditions identified were an inoculum of 10(4) CFU/ml, a temperature of incubation of 28 degrees C, an incubation period of 7 days, and MIC-0.

Indexed as

Antifungal AgentsArthrodermataceaeClotrimazoleCulture MediaHumansItraconazoleMicrobial Sensitivity TestsNaphthalenesReproducibility of ResultsTemperatureTerbinafineAntifungal AgentsClotrimazoleCulture MediaItraconazoleNaphthalenesTerbinafine

Identifiers

PMID12409365
PMCPMC139645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.